TrentonRecruiter Since 2001
the smart solution for Trenton jobs

Senior Director of Investor Relations/Public Relations

Company: F2G
Location: Princeton
Posted on: January 15, 2022

Job Description:

The Role

Title : Senior Director of Investor Relations/Public Relations

Location : Princeton, NJ

Reporting to : Chief Financial Officer

About F2G

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections. F2G has discovered and developed a completely new class of antifungal agents called the orotomides. The orotomides have a distinct mechanism of action, selectively targeting fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway. This differentiates the orotomides from the currently marketed antifungal agents. Olorofim (formerly F901318) is F2G's leading candidate from this class and has fungicidal activity against a broad range of mold infections, including a variety of rare and resistant molds that cause life-threatening infections for which current therapies have limitations or are ineffective. Olorofim is in a Phase 2b open-label study focusing on rare and resistant invasive fungal infections including invasive aspergillosis (including azole-resistant strains), coccidioidomycosis and scedosporiosis (including lomentosporiosis). Olorofim has received orphan drug status from the European Medicines Agency and orphan drug status, Qualified Infectious Disease Product (QIDP) designation and Breakthrough Therapy designation from FDA. F2G is headquartered in the UK with subsidiaries in the US and Austria.

Our Vision

F2G's vision is to bring to market safe, convenient, and effective novel antifungal agents to challenge a global unmet need for therapies that are active against resistant infections and also against pathogens which have historically been difficult to treat. F2G's leading agent, Olorofim, is the first novel anti-fungal treatment developed in the past 20 years and is the only antifungal medication ever to be awarded a Breakthrough Therapy Designation for multiple designations by the FDA. F2G believes that Olorofim, and subsequent agents, will address some of the many challenges which face the treating physician and the patient with invasive fungal infections.

F2G opened its US headquarters in mid-2021 and is hiring key functions in preparation for launching Olorofim. One of the first roles to be filled is the Senior Director of Investor Relations/Public Relations (IR/PR). This individual will serve as the primary strategist on product launch, commercialization, and investor and public engagement of the F2G brand while ensuring SEC communications and other compliance requirements are fulfilled.

Key Responsibilities:

Devise and execute an effective investor relations engagement strategy.
Develop, implement, and oversee coordinated communications to F2G Investors and stakeholders.
Educate investors and stakeholders about the company, potential impact, and current and future business plans.
Coordinate and host investor engagement initiatives including one-on-one meetings, investor days, roadshows, and other events.
Work with the current CFO and other members of the finance team to analyze financial data and market projections to make informed decisions regarding corporate brand strategy.
Work with the CFO to devise and execute a dynamic marketing communications/brand awareness strategy in support of product launch and commercialization.
Manage creation and upkeep of all business communications materials, including slide decks, quarterly business reports, internal business communications, and SEC reporting.
Manage all external marketing communications to include both physical materials and digital platforms (i.e. the company website and social media), campaigns, company writeups, presentations, conference attendance, and communications to partner organizations.
Ensure that all business communications are compliant with SEC regulations and Regulation Fair Disclosure.
Stay up-to-date with key market trends in the industry and make adjustments to brand positioning and other marketing efforts to maximize impact.
Ensure that internal and external messaging is aligned.
Develop and maintain key relationships with external vendors.

What You Bring to The Table:

Bachelor's degree required; Master's in relevant subject matter preferred.
10-15 years of relevant experience in communications strategy and execution in support of marketing or investor relations at a biopharmaceutical or life sciences organization.
A thorough knowledge of SEC reporting and Regulation FD communications requirements.
Knowledge of financial reporting and modeling principles.
Exceptional communication skills and the ability to present complex information to multiple audiences in a comprehensive manner.

This Job Is Right for You If:

You are a self-starter.
You thrive in a fast-paced startup environment with tight deadlines.
You can utilize data analysis to inform strategic decision-making.
Have excellent time and project management skills.
Are passionate about educating diverse audiences about treatments for rare diseases.

To apply, please visit our Careers page at www.f2g.com and submit your resume to careers@f2g.com.

Engage with us on our LinkedIn page as well at https://www.linkedin.com/company/f2g/

Keywords: F2G, Trenton , Senior Director of Investor Relations/Public Relations, Executive , Princeton, New Jersey

Click here to apply!

Didn't find what you're looking for? Search again!

I'm looking for
in category
within


Log In or Create An Account

Get the latest New Jersey jobs by following @recnetNJ on Twitter!

Trenton RSS job feeds